ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 641 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated Advanced KRAS p.G12D-mutated NSCLC and PADC EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers MOST POPULAR Study Suggests Watching Disney Movies May Improve Quality of Life for... May 26, 2020 Study Estimates That 22% Of Breast Cancers Are Overdiagnosed And Won’t... January 30, 2020 Estimate of the Global Economic Cost of the Most Prevalent Cancers... March 13, 2023 Coming Full Circle on Cancer and Extrachromosomal DNA May 10, 2023 Load more HOT NEWS Cancer in My Community: Improving Access to Palliative Care in Indonesia Καρκίνος οισοφάγου Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer ESMO Announces Results of 2025 Elections
